A Review Of Clinical Trials On LARIAT Device

Overview

Journal J Atr Fibrillation

Date 2016 Dec 14

PMID 27957212

Citations 2

Authors

Payam Safavi Naeini

Abdi Rasekh

Affiliations

Soon will be listed here.

Abstract

The risk of embolic stroke is 5 times higher among patients with atrial fibrillation (AF) compared with those without AF. More than 90% of thrombi form in the left atrial appendage (LAA) in AF. The purpose of this review is to determine the efficacy and safety of the left atrial appendage (LAA) closure via a percutaneous LAA ligation approach, thus preventing a stroke among patients with AF and contraindication to oral anticoagulant therapy.

Citing Articles

A Comprehensive Review of Percutaneous and Surgical Left Atrial Appendage Occlusion.

Swieczkowski M, Dabrowski E, Muszynski P, Pogorzelski P, Jemielita P, Dudzik J J Cardiovasc Dev Dis. 2024; 11(8).

PMID: 39195142 PMC: 11354510. DOI: 10.3390/jcdd11080234.

Closure of Left Atrial Appendage to Prevent Stroke: Devices and Status.

Safavi-Naeini P, Rasekh A Tex Heart Inst J. 2018; 45(3):172-174.

PMID: 30072856 PMC: 6059505. DOI: 10.14503/THIJ-18-6693.

References

Feinberg W, Blackshear J, Laupacis A, Kronmal R, Hart R . Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med. 1995; 155(5):469-73. View

Jones W, Williams L, Meschia J . Validating the Questionnaire for Verifying Stroke-Free Status (QVSFS) by neurological history and examination. Stroke. 2001; 32(10):2232-6. DOI: 10.1161/hs1001.096191. View

Malladi V, Naeini P, Razavi M, Collard C, Anton J, Tolpin D . Endovascular ablation of atrial fibrillation. Anesthesiology. 2014; 120(6):1513-9. DOI: 10.1097/ALN.0000000000000261. View

Albers G, Dalen J, Laupacis A, Manning W, Petersen P, Singer D . Antithrombotic therapy in atrial fibrillation. Chest. 2001; 119(1 Suppl):194S-206S. DOI: 10.1378/chest.119.1_suppl.194s. View

Stafford R, Singer D . Recent national patterns of warfarin use in atrial fibrillation. Circulation. 1998; 97(13):1231-3. DOI: 10.1161/01.cir.97.13.1231. View

Lin H, Wolf P, Beiser A, Kase C, Benjamin E, DAgostino R . Stroke severity in atrial fibrillation. The Framingham Study. Stroke. 1996; 27(10):1760-4. DOI: 10.1161/01.str.27.10.1760. View

Massumi A, Chelu M, Nazeri A, May S, Afshar-Kharaghan H, Saeed M . Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation. Am J Cardiol. 2013; 111(6):869-73. DOI: 10.1016/j.amjcard.2012.11.061. View

Go A, Mozaffarian D, Roger V, Benjamin E, Berry J, Borden W . Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2012; 127(1):e6-e245. PMC: 5408511. DOI: 10.1161/CIR.0b013e31828124ad. View

Connolly S, Ezekowitz M, Yusuf S, Eikelboom J, Oldgren J, Parekh A . Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009; 361(12):1139-51. DOI: 10.1056/NEJMoa0905561. View

10.

Bartus K, Han F, Bednarek J, Myc J, Kapelak B, Sadowski J . Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. J Am Coll Cardiol. 2012; 62(2):108-118. DOI: 10.1016/j.jacc.2012.06.046. View

11.

Stone D, Byrne T, Pershad A . Early results with the LARIAT device for left atrial appendage exclusion in patients with atrial fibrillation at high risk for stroke and anticoagulation. Catheter Cardiovasc Interv. 2013; 86(1):121-7. DOI: 10.1002/ccd.25065. View

12.

Camm A, Kirchhof P, Lip G, Schotten U, Savelieva I, Ernst S . Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010; 31(19):2369-429. DOI: 10.1093/eurheartj/ehq278. View

13.

Koneru J, Badhwar N, Ellenbogen K, Lee R . LAA ligation using the LARIAT suture delivery device: tips and tricks for a successful procedure. Heart Rhythm. 2014; 11(5):911-21. DOI: 10.1016/j.hrthm.2014.01.022. View

14.

Wolf P, Abbott R, Kannel W . Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991; 22(8):983-8. DOI: 10.1161/01.str.22.8.983. View

15.

Cardona L, Ana G, Luisa B, Leal A, Antonio F, Lidia S . Thrombus formation on a left atrial appendage closure device. Circulation. 2011; 124(14):1595-6. DOI: 10.1161/CIRCULATIONAHA.110.004135. View

16.

Spinler S, Shafir V . New oral anticoagulants for atrial fibrillation. Circulation. 2012; 126(1):133-7. DOI: 10.1161/CIRCULATIONAHA.112.099283. View

17.

Go A, Hylek E, Borowsky L, Phillips K, Selby J, Singer D . Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med. 1999; 131(12):927-34. DOI: 10.7326/0003-4819-131-12-199912210-00004. View

18.

Furie K, Goldstein L, Albers G, Khatri P, Neyens R, Turakhia M . Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012; 43(12):3442-53. DOI: 10.1161/STR.0b013e318266722a. View

19.

Han F, Bartus K, Lakkireddy D, Rojas F, Bednarek J, Kapelak B . The effects of LAA ligation on LAA electrical activity. Heart Rhythm. 2014; 11(5):864-870. PMC: 4617558. DOI: 10.1016/j.hrthm.2014.01.019. View